Skip to main content

452 Pill - blue capsule/oblong, 24mm

Pill with imprint 452 is Blue, Capsule/Oblong and has been identified as Mesalamine Extended-Release 0.375 g. It is supplied by Zydus Pharmaceuticals (USA) Inc.

Mesalamine is used in the treatment of Crohn's Disease, Maintenance; Inflammatory Bowel Disease; Ulcerative Colitis, Active; Ulcerative Colitis, Maintenance; Ulcerative Colitis and belongs to the drug class 5-aminosalicylates. excluding Asacol and Asacol HD: There is no proven risk in humans during pregnancy. Asacol and Asacol HD: Risk cannot be ruled out during pregnancy. Mesalamine 0.375 g is not a controlled substance under the Controlled Substances Act (CSA).

Images for 452

Mesalamine extended-release 0.375 g 452

Mesalamine Extended-Release

Imprint
452
Strength
0.375 g
Color
Blue
Size
24.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
5-aminosalicylates
Pregnancy Category
B - No proven risk in humans - excluding Asacol and Asacol HD, C - Risk cannot be ruled out - Asacol and Asacol HD
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals (USA) Inc.
Manufacturer
Cadila Healthcare Limited
National Drug Code (NDC)
68382-0452
Inactive Ingredients
ethylcellulose (10 mPa.s), hypromellose 2910 (5 mPa.s), methacrylic acid - methyl methacrylate copolymer (1:1), talc, triethyl citrate, FD&C Blue No. 1, gelatin, water, sodium lauryl sulfate, titanium dioxide, ferrosoferric oxide, potassium hydroxide, propylene glycol, shellac, sucrose, corn starch

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "452"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.